Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.85 CNY | -1.15% |
|
+2.35% | -17.03% |
| Market Cap | 25.32B 3.75B 3.26B 3.04B 2.79B 5.26B 357B 5.36B 35.86B 14.04B 178B 14.08B 13.77B 588B | P/E 2024 |
10.7x | P/E 2025 | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 21.06B 3.12B 2.71B 2.53B 2.32B 4.38B 297B 4.46B 29.83B 11.68B 148B 11.71B 11.45B 489B | EV / Sales 2024 |
2.3x | EV / Sales 2025 | 5.39x |
| Free-Float |
31.71% | Yield 2024 |
4.16% | Yield 2025 | 10.5% |
| 1 day | -1.15% | ||
| 1 week | +2.35% | ||
| Current month | -1.15% | ||
| 1 month | -5.30% | ||
| 3 months | -6.77% | ||
| 6 months | -11.98% | ||
| Current year | -17.03% |
| 1 week | 36.4 |  | 38.92 |
| 1 month | 36.1 | | 40.36 |
| Current year | 34.7 | | 48.2 |
| 1 year | 34.7 | | 50.97 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ma
DFI | Director of Finance/CFO | 48 | 2023-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 56 | 2017-10-09 |
Jian Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lei Wang
CHM | Chairman | 55 | 2024-11-25 |
Hong Zhou
BRD | Director/Board Member | 56 | 2012-11-30 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 2021-12-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.15% | +2.35% | -2.35% | -2.70% | 3.75B | |
| -1.08% | +2.29% | -7.11% | -2.86% | 13.81B | |
| -0.80% | +2.67% | -29.01% | -49.86% | 5.3B | |
| +1.43% | +6.95% | +7.16% | +11.02% | 5.23B | |
| -1.01% | -0.12% | +2.26% | -32.06% | 4.13B | |
| +0.04% | -0.37% | -0.81% | +7.01% | 3.66B | |
| -1.36% | -0.13% | -4.56% | +15.64% | 3.52B | |
| +1.27% | +0.31% | -13.17% | -21.65% | 2.49B | |
| +0.39% | +3.40% | -1.58% | +53.42% | 1.92B | |
| +0.48% | +3.38% | -39.23% | -11.73% | 1.77B | |
| Average | -0.18% | +2.68% | -8.84% | -3.38% | 4.56B | |
| Weighted average by Cap. | -0.44% | +2.52% | -7.42% | -6.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.31B 1.08B 940M 878M 806M 1.52B 103B 1.55B 10.35B 4.05B 51.41B 4.06B 3.97B 170B | 4.92B 728M 633M 591M 542M 1.02B 69.37B 1.04B 6.96B 2.73B 34.6B 2.73B 2.67B 114B |
| Net income | 2.23B 330M 287M 268M 246M 463M 31.45B 472M 3.16B 1.24B 15.68B 1.24B 1.21B 51.73B | 2.13B 315M 274M 256M 235M 443M 30.06B 451M 3.02B 1.18B 14.99B 1.18B 1.16B 49.45B |
| Net Debt | -3.91B -578M -502M -469M -431M -812M -55.11B -826M -5.53B -2.17B -27.48B -2.17B -2.12B -90.64B | -4.26B -630M -548M -511M -469M -885M -60.05B -900M -6.03B -2.36B -29.95B -2.37B -2.31B -98.78B |
Employees
3,890
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | CN¥37.85 | -1.15% | 3,389,800 |
| 26-07-31 | CN¥38.29 | -0.03% | 3,263,400 |
| 26-07-30 | CN¥38.30 | +0.52% | 4,169,400 |
| 26-07-29 | CN¥38.10 | +4.58% | 6,350,604 |
| 26-07-28 | CN¥36.43 | -1.49% | 3,610,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
